**Profluent** is an AI-first protein design company with the slogan "Decoding the language of life with AI." Founded in 2022, the company is headquartered in Emeryville, CA, United States. Profluent develops deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. The company has received a significant amount of support from leading investors, including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. In its latest funding round on 21 March 2024, Profluent secured an investment of $35.00M, with participation from Air Street Capital, Insight Partners, Spark Capital, AIX Ventures, Jeff Dean, and Convergent Ventures. For more information about Profluent's mission and activities, visit their website at profluent.bio.
No recent news or press coverage available for Profluent.